| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/09/2000 | EP1025123A2 Method for the production of human blood cytokines |
| 08/09/2000 | EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 08/09/2000 | EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR |
| 08/09/2000 | EP1024829A1 Tolerogenic fragments of natural allergens |
| 08/09/2000 | EP1024828A1 NOVEL pheS (BETA) |
| 08/09/2000 | EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 08/09/2000 | EP1024826A1 PASSIVE IMMUNIZATION AGAINST $i(CLOSTRIDIUM DIFFICILE) DISEASE |
| 08/09/2000 | EP1024825A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 08/09/2000 | EP1024822A1 Cd8 as an inhibitor of the cellular immune system |
| 08/09/2000 | EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 08/09/2000 | EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/09/2000 | EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 08/09/2000 | EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor |
| 08/09/2000 | EP0663010B1 Methods for increasing secretion of overexpressed proteins |
| 08/09/2000 | EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 08/09/2000 | EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 08/09/2000 | EP0568645B1 Mixed specificity fusion proteins |
| 08/09/2000 | EP0556171B1 Growth hormone antagonists |
| 08/09/2000 | EP0533846B1 The ciliary neurotrophic factor receptor |
| 08/09/2000 | CN1262689A Isolated dendritic cell membrane protein genes |
| 08/09/2000 | CN1262688A Integrin binding peptide and use thereof |
| 08/09/2000 | CA2327264A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide |
| 08/08/2000 | US6100453 Genetically engineering plants against infection; transforming pear cultivars with a gene which encodes for a lytic protein, recovering hybrid pears which lack sensitivity to plant disease |
| 08/08/2000 | US6100451 Nucleic acid sequences associated with transcriptional control in plants; for the development of disease resistance plants |
| 08/08/2000 | US6100449 Nucleotide sequences which code protein which prevents or reduces fungal infection |
| 08/08/2000 | US6100443 Universal donor cells |
| 08/08/2000 | US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals |
| 08/08/2000 | US6100389 Nucleotide sequences coding protein: for stem cell mobilization, myloid and neuronal cell protection; for the treatment and prevention of tumors and parasitic infection; wound healing agents; antitumor agents |
| 08/08/2000 | US6100388 Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| 08/08/2000 | US6100387 Chimeric polypeptides containing chemokine domains |
| 08/08/2000 | US6100386 Nucleotide sequences coding polypeptide associated with signal transductionand tyrosine kinases; for the treatment of cancers; anticarcinogenic agents |
| 08/08/2000 | US6100384 Antibodies immunologically specific for a signal mediator protein that induces cellular morphological alterations |
| 08/08/2000 | US6100380 Amino acid sequences; for the treatment of infections, anemias, allergies and immune defects |
| 08/08/2000 | US6100379 Artificial generated amino acid sequences; for the development of diagnostic tools for the detection of connective tissue degradation by-products |
| 08/08/2000 | US6100378 Amplification of polypeptide joining to sex cells |
| 08/08/2000 | US6100377 Aromatically adjusted and confined amino acid sequences; for the development of more efficient synthetic polypeptides |
| 08/08/2000 | US6100376 A21, B30, modified insulin derivatives having an altered action profile |
| 08/08/2000 | US6100296 Modulation of inflammation related to columnar epithelia |
| 08/08/2000 | US6100243 Method of sensitizing tumor cells with adenovirus E1A |
| 08/08/2000 | US6100242 Gene therapies for enhancing cardiac function |
| 08/08/2000 | US6100241 Nucleic acids encoding an immunogenic fragment of eimeria lactate dehydrogenase (ldh) which will react with antiserum raised against the ldh; preparing a vector vaccine against coccidiosis; administering to prevent coccidiosis in birds |
| 08/08/2000 | US6100236 Method and composition for treating thrombosis |
| 08/08/2000 | US6100235 Methods of treating immune and inflammatory response with IL-17 receptors |
| 08/08/2000 | US6100099 Chromatographic aparatus for the immunological detection of compounds; for the detection of target nucleotide sequences, antigens and antibodies |
| 08/08/2000 | US6100088 Viral vaccines |
| 08/08/2000 | US6100087 Ribozymes targeted to human CCR5 mRNA |
| 08/08/2000 | US6100085 Isolated, recombinantly-produced 59.5 kilodalton human excitatory amino acid transporter, eaat1; for drug screening of modulators |
| 08/08/2000 | US6100072 Preparing liquid or lyophilized reagent by mixing surfactant solubilized tissue factor with surfactant-free solution, suspension, or dispersion of phospholipid vessicle, incubating mixture to produce reagent; also fibrinogen levels |
| 08/08/2000 | US6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| 08/08/2000 | US6100070 G-CSF receptor agonists |
| 08/08/2000 | US6100069 Amino acid sequence of peptidyl-propyl cis/trans isomerase involved in protein folding; for screening bacteriostats, bactericides, and antibiotics; diagnosis and prophylaxis |
| 08/08/2000 | US6100068 Method of protein production using mitochondrial translation system |
| 08/08/2000 | US6100067 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes |
| 08/08/2000 | US6100066 Nucleotide sequence encoding an immunogenic lipoprotein b polypeptide; for vaccines used in prevention and treatment of infections |
| 08/08/2000 | US6100065 Recombinant polypeptide particles with high immunogenicity; comprises portion of pre-s1 peptide and surface antigen peptide |
| 08/08/2000 | US6100064 Increasing secretion by culturing cells transformed with recombinant vector encoding cytomegalovirus gb protein that may have deactivated protease site and lacks transmembrane encoding domain but has cytoplasmic domain |
| 08/08/2000 | US6100062 Expression system for HSCLOCK |
| 08/08/2000 | US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction |
| 08/08/2000 | US6100058 Gap12 genes and their uses |
| 08/08/2000 | US6100057 Introducing regulatory sequences which link to endogenous heme biosynthetic enzymes or copies of nucleotide sequences encoding heme biosynthetic enzymes with linked regulatory sequences, culturing fungus, recovering secreted hemoprotein |
| 08/08/2000 | US6100056 Lactococcus which does not secrete a natural nisin, but which expresses genes for nisin modification, immunity, and translocation out of cell; for production of mutant nisins including acid stable variant |
| 08/08/2000 | US6100055 DNA encoding fα-2m-binding protein and protein encoded thereby |
| 08/08/2000 | US6100054 Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms |
| 08/08/2000 | US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior |
| 08/08/2000 | US6100046 Methods of identifying modulators of alpha9, a novel acetylcholine-gated ion channel receptor subunit |
| 08/08/2000 | US6100044 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 08/08/2000 | US6100042 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 08/08/2000 | US6100041 Human prohormone convertase 4 |
| 08/08/2000 | US6100034 Detection of retroviral subtypes based upon envelope specific sequences |
| 08/08/2000 | US6100032 Human Smad3 and Smad4 are sequence-specific transcription activators |
| 08/08/2000 | US6100031 Hybridization assay using specific nucleotide sequence as probe |
| 08/08/2000 | US6100025 Dna encoding a mammalian cyclic nucleotide phosphodiesterase and which are inserts in plasmids ppde46 (atcc no. 69552), ppde43 (atcc no 69551), and ppde339 (atcc no. 69550) |
| 08/08/2000 | US6099848 Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use |
| 08/08/2000 | US6099847 Genetic eengineering |
| 08/08/2000 | US6099846 Immunocomplex; forming antibodies |
| 08/08/2000 | US6099843 Used to protect animals from diseases caused by parasitic helminths |
| 08/08/2000 | US6099842 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin |
| 08/08/2000 | US6099841 Include hgf receptor antibodies and fragments thereof; used to treat a pathological liver condition |
| 08/08/2000 | US6099840 Variant hbsag protein of fragment thereof displaying the antigenicity of hepatitis b virus surface antigen |
| 08/08/2000 | US6099837 Pharmaceutical preparation for treating blood coagulation disorders |
| 08/08/2000 | US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/08/2000 | CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle |
| 08/08/2000 | CA2219795C Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/08/2000 | CA2216165C Ndf peptides |
| 08/08/2000 | CA2207505C Neurological drug screens |
| 08/08/2000 | CA2138270C Prosthetic devices having enhanced osteogenic properties |
| 08/08/2000 | CA2125376C Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof |
| 08/08/2000 | CA2071907C Bcrf1 proteins as inhibitors of interferon-y |
| 08/08/2000 | CA2070664C Antisense oligonucleotide inhibition of papillomavirus |
| 08/08/2000 | CA2002218C Neoglycoproteins, the preparation and use thereof |
| 08/08/2000 | CA2000893C Biologically active lipoprotein and its use |
| 08/08/2000 | CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function |
| 08/08/2000 | CA1341079C Large scale method for purification of high purity heparinase |
| 08/08/2000 | CA1341074C Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine |
| 08/08/2000 | CA1341073C Vectors and methods for expression of human protein c activity |
| 08/03/2000 | WO2000045334A1 Protein modeling tools |
| 08/03/2000 | WO2000045322A1 Determining protein function and interaction from genome analysis |
| 08/03/2000 | WO2000045176A2 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 08/03/2000 | WO2000044927A1 Pskg from staphylococcus aureus |
| 08/03/2000 | WO2000044918A1 Methods and means for modification of plant characteristics using the vernalization gene vrn2 |